NCT03200015View on ClinicalTrials.gov

Rituximab, Cyclophosphamide, Vincristine and Prednisone (R-CHOP) Plus Metformin in Diffuse Large-B-cell Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 1, 2017

Primary Completion Date

August 27, 2018

Study Completion Date

January 27, 2019

Conditions
Diffuse Large B Cell Lymphoma
Interventions
DRUG

Metformin

Potentially increasing the efficacy and safety of standard chemotherapy through several mechanisms

Trial Locations (1)

64610

Hospital Universitario Dr. José Eleuterio González, Monterrey

All Listed Sponsors
lead

Hospital Universitario Dr. Jose E. Gonzalez

OTHER

NCT03200015 - Rituximab, Cyclophosphamide, Vincristine and Prednisone (R-CHOP) Plus Metformin in Diffuse Large-B-cell Lymphoma | Biotech Hunter | Biotech Hunter